Entrada Therapeutics, Inc. (TRDA)
NASDAQ
Market Cap
$476M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
152 of 809
Rank in Industry
99 of 445
Largest Insider Buys in Sector
TRDA Stock Price History Chart
TRDA Stock Performance
About Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc., a biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its endosomal escape vehicle platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. The company's lead product candidate is ENTR-601-44, which is in preclinical trail for the treatment of Duchenne muscular dystrophy and myotonic dystrophy type 1. It also engages in the development of EEV-PMO-CAG for the treatment of myotonic dystrophy type 1. The company was formerly known as CycloPorters, Inc. and changed its name to Entrada Therapeutics, Inc. in October 2017. Entrada Therapeutics, Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.
Insider Activity of Entrada Therapeutics, Inc.
Over the last 12 months, insiders at Entrada Therapeutics, Inc. have bought $641,939 and sold $1.79M worth of Entrada Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Entrada Therapeutics, Inc. have bought $36.93M and sold $3.16M worth of stock each year.
Highest buying activity among insiders over the last 12 months: KIM PETER S (director) — $1.28M.
The last purchase of 25,000 shares for transaction amount of $364,673 was made by KIM PETER S (director) on 2024‑05‑14.
List of Insider Buy and Sell Transactions, Entrada Therapeutics, Inc.
| 2024-06-13 | Sale | Doshi Dipal | CEO | 1,000 0.0031% | $16.17 | $16,174 | -10.09% | |
| 2024-05-20 | Sale | Sethuraman Natarajan | Chief Scientific Officer | 9,675 0.0284% | $15.19 | $146,944 | +1.70% | |
| 2024-05-17 | Sale | Doshi Dipal | CEO | 1,200 0.0036% | $15.11 | $18,129 | +3.87% | |
| 2024-05-17 | Sale | Sethuraman Natarajan | Chief Scientific Officer | 8,305 0.0253% | $15.14 | $125,751 | +3.87% | |
| 2024-05-16 | Sale | Doshi Dipal | CEO | 1,800 0.0054% | $15.00 | $27,000 | +3.95% | |
| 2024-05-16 | Sale | Sethuraman Natarajan | Chief Scientific Officer | 1,000 0.003% | $15.00 | $15,000 | +3.95% | |
| 2024-05-14 | KIM PETER S | director | 25,000 0.0761% | $14.59 | $364,673 | +8.82% | ||
| 2024-05-09 | KIM PETER S | director | 2,200 0.0065% | $14.25 | $31,341 | +6.69% | ||
| 2024-05-08 | KIM PETER S | director | 2,276 0.0068% | $14.04 | $31,965 | +9.00% | ||
| 2024-04-08 | KIM PETER S | director | 2,600 0.0078% | $13.57 | $35,290 | +7.73% | ||
| 2024-03-28 | KIM PETER S | director | 1,512 0.0044% | $13.75 | $20,794 | +0.28% | ||
| 2024-03-26 | KIM PETER S | director | 2,750 0.0082% | $13.64 | $37,509 | +3.27% | ||
| 2024-03-25 | KIM PETER S | director | 3,180 0.0095% | $13.36 | $42,472 | +6.30% | ||
| 2024-03-22 | KIM PETER S | director | 3,118 0.0094% | $13.76 | $42,901 | +3.54% | ||
| 2024-03-21 | KIM PETER S | director | 704 0.0021% | $13.24 | $9,318 | +4.65% | ||
| 2024-03-20 | KIM PETER S | director | 1,128 0.0032% | $12.66 | $14,281 | +5.69% | ||
| 2024-03-19 | KIM PETER S | director | 900 0.0027% | $12.66 | $11,397 | +10.63% | ||
| 2024-03-06 | Sale | Dowden Nathan J | President & COO | 1,826 0.0055% | $12.32 | $22,499 | +11.54% | |
| 2024-03-06 | Sale | WENTWORTH KORY JAMES | Chief Financial Officer | 4,086 0.0123% | $12.31 | $50,285 | +11.54% | |
| 2024-02-15 | Sale | Doshi Dipal | CEO | 1,000 0.0031% | $15.00 | $15,000 | -8.59% |
Insider Historical Profitability
60.19%
| Doshi Dipal | CEO | 336375 0.7327% | $14.10 | 0 | 42 | |
| Sethuraman Natarajan | Chief Scientific Officer | 190052 0.4602% | $14.10 | 0 | 6 | |
| KIM PETER S | director | 92412 0.1873% | $14.10 | 11 | 0 | |
| WENTWORTH KORY JAMES | Chief Financial Officer | 74170 0.1487% | $14.10 | 0 | 21 | |
| Dowden Nathan J | Chief Operating Officer | 137204 0.1445% | $14.10 | 0 | 21 | |
| KREHER NERISSA | Chief Medical Officer | 40037 0.1201% | $14.10 | 0 | 18 | |
| BAKER BROS. ADVISORS LP | 10 percent owner | 4501658 13.5022% | $14.10 | 8 | 0 | +124.37% |
| Baker Bros. Advisors (GP) LLC | 4475208 13.4229% | $14.10 | 3 | 0 | +129.14% | |
| Foley Todd | 4425784 13.2746% | $14.10 | 1 | 0 | <0.0001% | |
| MPM BIOVENTURES 2018, L.P. | 10 percent owner | 4425784 13.2746% | $14.10 | 1 | 0 | <0.0001% |
| MPM BioVentures 2014, L.P. | 10 percent owner | 4425784 13.2746% | $14.10 | 1 | 0 | <0.0001% |
| Redmile Group, LLC | 10 percent owner | 1954420 5.862% | $14.10 | 1 | 0 | <0.0001% |
| PARMAR KUSH | 1132357 3.3964% | $14.10 | 1 | 0 | <0.0001% | |
| 5AM Ventures V, L.P. | 10 percent owner | 1132357 3.3964% | $14.10 | 1 | 0 | <0.0001% |
| Crowley John F | director | 5000 0.015% | $14.10 | 1 | 0 | +22.78% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Baker Bros Advisors LP | $68.95M | 14.41 | 4.87M | 0% | +$0 | 0.87 | |
| MPM Asset Management LLC | $62.71M | 13.11 | 4.43M | 0% | +$0 | 25.58 | |
| 5Am Venture Management Llc | $62.47M | 13.06 | 4.41M | 0% | +$0 | 4.21 | |
| T. Rowe Price | $39.02M | 8.16 | 2.75M | -8.52% | -$3.63M | 0.01 | |
| BlackRock | $21.06M | 4.4 | 1.49M | -1.09% | -$231,948.75 | <0.0001 | |
| Redmile Group | $18.19M | 3.8 | 1.28M | 0% | +$0 | 0.67 | |
| The Vanguard Group | $15.29M | 3.2 | 1.08M | +1.29% | +$194,724.14 | <0.0001 | |
| Wellington Management Company | $14.55M | 3.04 | 1.03M | -2% | -$296,719.80 | <0.01 | |
| StepStone Group | $10.79M | 2.26 | 761,277 | 0% | +$0 | 2.32 | |
| Tcg Crossover Management Llc | $8.29M | 1.73 | 584,955 | 0% | +$0 | 0.01 | |
| Geode Capital Management | $6.74M | 1.41 | 475,358 | +3.48% | +$226,417.72 | <0.01 | |
| State Street | $6.17M | 1.29 | 435,390 | +1.77% | +$107,096.85 | <0.0001 | |
| American Century Investments | $5.19M | 1.09 | 366,348 | +53.51% | +$1.81M | <0.01 | |
| Northern Trust | $2.82M | 0.59 | 199,342 | -0.67% | -$19,072.82 | <0.0001 | |
| Fidelity Investments | $2.38M | 0.5 | 167,921 | -68.64% | -$5.21M | <0.0001 | |
| Charles Schwab | $2.22M | 0.46 | 156,629 | +3.48% | +$74,690.07 | <0.01 | |
| BNY Mellon | $1.57M | 0.33 | 110,598 | -3.88% | -$63,226.55 | <0.0001 | |
| Morgan Stanley | $1.52M | 0.32 | 107,562 | +118.16% | +$825,515.57 | <0.0001 | |
| Moore Capital Management | $1.49M | 0.31 | 105,000 | 0% | +$0 | 0.03 | |
| Advantage Alpha Capital Partners Lp | $1.29M | 0.27 | 91,116 | -13.34% | -$198,677.61 | 0.25 | |
| Millennium Management LLC | $1.02M | 0.21 | 71,946 | +200.19% | +$679,862.55 | <0.01 | |
| Td Asset Management Inc | $1.01M | 0.21 | 71,308 | -40.2% | -$679,394.58 | <0.01 | |
| Citadel Advisors LLC | $987,309.00 | 0.21 | 69,676 | New | +$987,309.00 | <0.01 | |
| Nuveen | $809,631.00 | 0.17 | 57,137 | -29.03% | -$331,195.29 | <0.0001 | |
| Citigroup | $797,587.00 | 0.17 | 56,287 | +1,709.87% | +$753,518.29 | <0.01 | |
| The Manufacturers Life Insurance Company | $778,670.00 | 0.16 | 54,952 | -1.3% | -$10,244.91 | <0.01 | |
| Marshall Wace | $732,915.00 | 0.15 | 51,723 | New | +$732,915.00 | <0.01 | |
| Nan Fung Group | $695,492.00 | 0.15 | 49,082 | 0% | +$0 | 0.76 | |
| Corton Capital Inc | $582,982.00 | 0.12 | 41,142 | +43.97% | +$178,060.18 | 0.22 | |
| Squarepoint Ops LLC | $483,211.00 | 0.1 | 34,101 | New | +$483,211.00 | <0.01 | |
| Winton Capital Management | $461,304.00 | 0.1 | 32,555 | New | +$461,304.00 | 0.03 | |
| Natixis | $432,862.00 | 0.09 | 31,186 | 0% | +$0 | <0.01 | |
| Connor Clark & Lunn Investment Management Ltd | $436,209.00 | 0.09 | 30,784 | New | +$436,209.00 | <0.01 | |
| RhumbLine Advisers | $417,834.00 | 0.09 | 29,488 | +3.5% | +$14,112.95 | <0.0001 | |
| Schonfeld Group | $410,235.00 | 0.09 | 28,951 | New | +$410,235.00 | <0.01 | |
| New York Life Investment Management Llc | $367,201.00 | 0.08 | 25,914 | New | +$367,201.00 | <0.01 | |
| Ohio Strs | $364,000.00 | 0.08 | 25,700 | +6.64% | +$22,661.48 | <0.01 | |
| UBS | $332,556.00 | 0.07 | 23,469 | +4.42% | +$14,070.82 | <0.0001 | |
| Swiss National Bank | $325,910.00 | 0.07 | 23,000 | 0% | +$0 | <0.0001 | |
| Barclays | $318,000.00 | 0.07 | 22,517 | -29.04% | -$130,112.09 | <0.0001 | |
| Bank of America | $319,745.00 | 0.07 | 22,565 | -17.74% | -$68,936.82 | <0.0001 | |
| Martingale Asset Management L P | $261,466.00 | 0.06 | 18,452 | New | +$261,466.00 | 0.01 | |
| Goldman Sachs | $245,470.00 | 0.05 | 17,323 | -4.1% | -$10,500.10 | <0.0001 | |
| Man Group Plc | $238,184.00 | 0.05 | 16,809 | New | +$238,184.00 | <0.01 | |
| Credit Suisse | $227,457.00 | 0.05 | 16,052 | +1.24% | +$2,777.32 | <0.0001 | |
| Allspring Global Investments | $209,192.00 | 0.04 | 14,763 | +427.63% | +$169,544.29 | <0.0001 | |
| Harbor Capital Advisors Inc | $206,000.00 | 0.04 | 14,543 | New | +$206,000.00 | 0.03 | |
| Franklin Templeton Investments | $202,900.00 | 0.04 | 14,319 | +8.43% | +$15,771.19 | <0.0001 | |
| Arrowstreet Capital, Limited Partnership | $203,000.00 | 0.04 | 14,307 | New | +$203,000.00 | <0.0001 | |
| Cornercap Investment Counsel Inc | $186,236.00 | 0.04 | 13,143 | New | +$186,236.00 | 0.03 |